Government's Brief (March 19, 2018)

Defendants-Appellees' brief in the 340B Payment Reductions in the CY 2018 OPPS Final Rule suit.

The plaintiff hospitals and hospital trade associations seek to challenge a final rule that, in relevant part, adjusted for calendar year 2018 the payments made by the Centers for Medicare & Medicaid Services (CMS) under the Outpatient Prospective Payment System (OPPS or Payment System) in Medicare Part B for certain drugs covered by a program known as the 340B Program. See 82 Fed. Reg. 52,356 (Nov. 13, 2017) (final rule announcing the OPPS for calendar year 2018). Their claim is barred because Congress expressly precluded judicial and administrative review of adjustments to the Outpatient Prospective Payment System. See Amgen, Inc. v. Smith, 357 F.3d 103 (D.C. Cir. 2004).

Related Resources

Letter/Comment
Member
The information below supplements the March 29, 2018 memorandum AHA’s outside counsel prepared regarding 340B claims submission during the legal challenge to…
Letter/Comment
Member
Dear Noridian Healthcare Solutions: Since January 1, 2018, our hospital has been receiving payments for 340B drugs that reflect the new reimbursement rate of…
Letter/Comment
Member
Dear National Government Services: Since January 1, 2018, our hospital has been receiving payments for 340B drugs that reflect the new reimbursement rate of…